ГОСТ ISO/TS 21726-2021. Межгосударственный стандарт. Изделия медицинские. Система оценки биологического действия. Руководство по применению порога токсической опасности для оценки биосовместимости компонентов медицинских изделий

[1]

Renwick A.G. 2004. Toxicology databases and the concept of thresholds of toxicological concern as used by the JECFA for the safety evaluation of flavoring agents. Toxicology Letters 149(1 - 3): 223 - 224

[2]

Kroes R., Renwick A., Cheeseman M., Kleiner J., Mangelsdorf I., Piersma A., Schilter B., Schlatter J., Van Schothorst F., and Vos J.G. 2004 Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food and Chemical Toxicology 42(1): 65 - 83

[3]

Munro I.C. 1990. Safety assessment procedures for indirect food additives: an overview. Report of a workshop. Regul Toxicol Pharmacol. 12(1): 2 - 12

[4]

U.S. FDA. 1995 Food additives: Threshold of regulation for extractables used in food-contact articles (Final rule - 21 CFR Parts 5, 25, 170, 171, and 174, Docket Nos. 77P-0122 and 92N-0181). Fed Regist (US) 60(136): 36582 - 36596

[5]

Munro I.C., Ford R.A., Kennepohl E., and Sprenger J.G. 1996. Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. Food Chem Toxicol 34(9): 829 - 867

[6]

Cheeseman M., Machuga E., and Bailey A.A. 1999. A tiered approach to threshold of regulation. Food and Chemical Toxicology 37(4): 387 - 412

[7]

Kroes R., Kleiner J., Renwick A. 2005. The threshold of toxicological concern concept in risk assessment. Toxicol Sci 86(2): 226 - 230

[8]

Dewhurst I. and Renwick A.G. 2013 Evaluation of the Threshold of Toxicological Concern (TTC) - Challenges and approaches. Regulatory Toxicology and Pharmacology 65(1): 168 - 177

[9]

ICH. 2017 Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk M7(R1). ICH Harmonised Tripartite Guideline. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use Geneva, Switzerland: Available at http://www.ich.org

[10]

SCCS. SCHER, SCENIHR. 2012. Joint Opinion on the Use of the Threshold of Toxicological Concern (TTC) Approach for Human Safety Assessment of Chemical Substances with focus on Cosmetics and Consumer Products. Report No. SCCP/1171/08. Available at https://ec.europa.eu/health/scientific_committees/consumer_safety/requests_en

[11]

EFSA-WHO. 2016. Review of the Threshold of Toxicological Concern (TTC) approach and development of new TTC decision tree. European Food Safety Authority and World Health Organization. EFSA Supporting publication 2016:EN-1006. Available at http://www.efsa.europa.eu/

[12]

Rulis A.M. 2018. Chapter 2. De minimis and the threshold of regulation. In Food Protection and Technology (Editor Charles W. Felix). CRC Revivals. CRC Press. New York, NY

[13]

Munro I.C., Renwick A.G., Danielewska-Nikiel. 2008. The threshold of toxicological concern (TTC) in risk assessment. Toxicology letters 180(2): 151 - 156

[14]

EMEA. 2006. Guideline on the Limits of Genotoxic Impurities. European Medicines Agency, Committee for Medicinal Products for Human Use. European Agency for the Evaluation of Medicinal Products (EMEA); London, UK. Available at http://www.ema.europa.eu/ema/

[15]

U.S. FDA. 2007. Part 170 - Food additives. Section § 170.39 - Threshold of regulation for extractables used in food-contact articles. In: U.S. Code of Federal Regulations Title 21: Food and Drugs. Food and Drug Administration (FDA). U.S. Government Printing Office (GPO); Washington DC, pp. 18 - 20. Available at https://www.ecfr.gov

[16]

Cramer G.M, Ford R.A., and Hall R.L. 1978. Estimation of toxic hazard - A decision tree approach. Food Cosmet Toxicol. 16(3): 255 - 276

[17]

L., Mauthe R.J., Riley C.M., Andino M.M., De Antonis D., Beels C., DeGeorge J., De Knaep A., Ellison D., Fagerland J. 2006. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regulatory Toxicology and Pharmacology. 44(3): 198 - 211

[18]

Alan Boobis, Robert Budinsky, Shanna Collie, Kevin Crofton, Michelle Embry, Susan Felter, Richard Hertzberg, David Kopp, Gary Mihlan, Moiz Mumtaz, Paul Price, Keith Solomon, Linda Teuschler, Raymond Yang, and Rosemary Zaleski, (2011). Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment. Critical Reviews in Toxicology, 2011, 1 - 14

[19]

Ashby J. and Tennant R.W. 1991. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Research/Reviews in Genetic Toxicology. 257(3): 229 - 306

[20]

KROES R., GALLI C., MUNRO I. Schilter, Tran L.-A., Walker R., and G. (2000). Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. Food and Chemical Toxicology, 38(2): 255 - 312

[21]

Munro I., Kennepohl E., and Kroes R. (1999). A procedure for the safety evaluation of flavouring substances. Food and Chemical Toxicology, 37(2): 207 - 232

[22]

Joseph A.M., George B., Madhusoodanan K.N., and Alex R. (2015). Current status of sulphur vulcanization and devulcanization chemistry: Process of vulcanization. Rubber Science. 28(1): 82 - 121

[23]

Roberts D.W., Aptula A., Schultz T.W., Shen J., Api A.M., Bhatia S., and Kromidas L. (2015). A practical guidance for Cramer class determination. Regulatory Toxicology and Pharmacology. 73(3): 971 - 984

[24]

Bhatia S., Schultz T., Roberts D., Shen J., Kromidas L., and Marie Api A. (2015). Comparison of Cramer classification between Toxtree, the OECD QSAR Toolbox and expert judgment. Regulatory Toxicology and Pharmacology. 71(1): 52 - 62

[25]

ISO 18562 (all parts) Biocompatibility evaluation of breathing gas pathways in healthcare applications (Оценка биологической совместимости путей для дыхательных газов в здравоохранении)

УДК 615.46:002:006.354

МКС 11.100.20

IDT

Ключевые слова: медицинские изделия, система оценки биологического действия, порог токсической опасности, оценка биосовместимости компонентов медицинских изделий, идентифицированный компонент, экстрагируемое вещество